Rapid tumor development with a modified MCF-7 xenograft model

被引：0
|
作者：
Hale, LV
Layman, NK
Wilson, P
Short, LL
Magee, DE
Wightman, SR
FuchsYoung, R
机构：
[1] ELI LILLY & CO,LILLY CORP CTR,LILLY RES LABS,DEPT ENDOCRINOL,INDIANAPOLIS,IN 46285
[2] ELI LILLY & CO,LILLY CORP CTR,LILLY RES LABS,DEPT LAB ANIM SERV,INDIANAPOLIS,IN 46285
来源：
LABORATORY ANIMAL SCIENCE | 1997年 / 47卷 / 01期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：82 / 85
页数：4
相关论文
共 50 条
  • [11] The Addition of a Pregnenolone Pendant Group Enhances the Anticancer Properties of Titanocene Dichloride in a MCF-7 Xenograft Model
    Ramos, Gladiany
    Loperena, Yaliz
    Ortiz, Giovanni
    Reyes, Fiorella
    Szeto, Ada
    Vera, Jose
    Velez, Javier
    Morales, Jessica
    Morrero, Deborah
    Castillo, Linnette
    Dharmawardhane, Surangani
    Melendez, Enrique
    Washington, A. Valance
    ANTICANCER RESEARCH, 2014, 34 (04) : 1609 - 1615
  • [12] Tamoxifen increases apoptosis but does not influence markers of proliferation in an MCF-7 xenograft model of breast cancer
    Hawkins, RA
    Arends, MJ
    Ritchie, AA
    Langdon, S
    Miller, WR
    BREAST, 2000, 9 (02): : 96 - 106
  • [13] Idoxifene antagonism of oestradiol-dependent MCF-7 breast cancer xenograft growth
    Johnston, SRD
    Dowsett, M
    Riddler, S
    Jarman, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S81 - S81
  • [14] Temozolomide resistance in MCF-7 breast cancer model
    Kato, Yoshinori
    Okollie, Baasil
    Raman, Venu
    Vesuna, Farhad
    Wildes, Flonne
    Zhao, Ming
    Baker, Sharyn D.
    Artemov, Dmitri
    CANCER RESEARCH, 2006, 66 (08)
  • [15] The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
    Jana Divisova
    Isere Kuiatse
    ZaWaunyka Lazard
    Heidi Weiss
    Franzanne Vreeland
    Darryl L. Hadsell
    Rachel Schiff
    C. Kent Osborne
    Adrian V. Lee
    Breast Cancer Research and Treatment, 2006, 98 : 315 - 327
  • [16] The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
    Divisova, Jana
    Kuiatse, Isere
    Lazard, ZaWaunyka
    Weiss, Heidi
    Vreeland, Franzanne
    Hadsell, Darryl L.
    Schiff, Rachel
    Osborne, C. Kent
    Lee, Adrian V.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 98 (03) : 315 - 327
  • [17] Trastuzumab and liposomal doxorubicin in the treatment of MCF-7 xenograft tumor-bearing mice: Combination does not affect drug serum levels
    Waterhouse, DN
    Denyssevych, T
    Hudon, N
    Chia, S
    Gelmon, KA
    Bally, MB
    PHARMACEUTICAL RESEARCH, 2005, 22 (06) : 915 - 922
  • [18] Antitumor effect of Iso-mukaadial acetate in MCF-7 human cancer xenograft models
    Raphela-Choma, Portia
    Motadi, Lesetja R.
    Choene, Mpho S.
    CANCER RESEARCH, 2023, 83 (07)
  • [19] TEICHOIC ACID MODULATES THE ADHESIVE PROPERTIES OF MCF-7 TUMOR CELLS
    Nikolaenko, T.
    Senchilo, N.
    Garmanchuk, L.
    Nikulina, V.
    Dzhus, O.
    Kosovska, M.
    Stupak, Y.
    BREAST, 2013, 22 : S27 - S28
  • [20] Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids
    Furbert-Harris, PM
    Laniyan, I
    Harris, D
    Dunston, GM
    Vaughn, T
    Abdelnaby, A
    Parish-Gause, D
    Oredipe, OA
    ANTICANCER RESEARCH, 2003, 23 (1A) : 71 - 78
12345